BHC News and Press, Bausch Health Companies Inc.

2026-02-25 10:03:10 ET Shares of skin disease concern Oruka Therapeutics, Inc. ( ORKA ) have more than doubled since its IL-23p19 antagonist ORKA-001 demonstrated a half-life four times greater than Skyrizi in a Phase 1 study. The once or twice-yearly psoriasis candidate is undergoi...

Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant® Touch Laser in Canada Canada NewsWire LAVAL, QC , Feb. 23, 2026 /CNW/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and Solta M...

2026-02-19 10:07:31 ET Last October 2025, Bausch Health Companies Inc. ( BHC ) jumped by 1% after it posted third quarter results . This time, the fourth-quarter bottom line missed expectations. Both its revenue for Q4 and revenue guidance for 2026 exceeded consensus. However, t...

Bausch Health's OraPharma Celebrates 25 Years of ARESTIN® (minocycline HCl) Microspheres PR Newswire The only FDA‑approved locally applied antibiotic used with scaling and root planing (SRP) marks a quarter‑century of clinical use LAVAL, QC , Feb. 19, 2026 /...

2026-02-18 20:15:31 ET More on Bausch Health Companies Bausch Health Companies Inc. (BHC) Q4 2025 Earnings Call Transcript Bausch Health: RED-C Failure Leaves Blockbuster Xifaxan Without A Successor Bausch Health Companies Inc. (BHC) Presents at 44th Annual J.P. Morg...

2026-02-18 20:14:56 ET Bausch Health Companies Inc. (BHC) Q4 2025 Earnings Call February 18, 2026 5:00 PM EST... Read the full article on Seeking Alpha For further details see: Bausch Health Companies Inc. (BHC) Q4 2025 Earnings Call Transcript

2026-02-18 18:51:45 ET Image source: The Motley Fool. Wednesday, Feb. 18, 2026 at 5 p.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-02-18 17:19:23 ET More on Bausch Health Companies Bausch Health: RED-C Failure Leaves Blockbuster Xifaxan Without A Successor Bausch Health Companies Inc. (BHC) Presents at 44th Annual J.P. Morgan Healthcare Conference Bausch Health Companies Inc. (BHC) Presents...

BAUSCH HEALTH ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS Canada NewsWire Fourth Quarter Consolidated Revenues of $2.80 billion, up 9% on a Reported basis and up 6% on an Organic (non-GAAP) 1   basis over the prior year period Full-Year Consolidated Revenues of ...

2026-02-18 15:59:32 ET More on Bausch Health Companies Bausch Health: RED-C Failure Leaves Blockbuster Xifaxan Without A Successor Bausch Health Companies Inc. (BHC) Presents at 44th Annual J.P. Morgan Healthcare Conference Bausch Health Companies Inc. (BHC) Presents...